Clinical Trial Update: Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial of lenalidomide for previously untreated advanced-stage follicular lymphoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma, Follicular Lymphoma | Phase 1, Phase 2 | Status: WITHDRAWN